Prof. Colin McGuckin, creator of "mini liver" & Scientific Director, Cryo-Save, to visit India

Cryo-Save India today announced that their new Scientific Director Professor Colin McGuckin, will be visiting India between February 27 to March 3, 2009. Prof. McGuckin who made a medical breakthrough in 2005 with the creation of the world’s first “mini liver” from umbilical cord blood will share his plans on integrating new scientific technologies which may substantially speed up treatments for life-threatening illnesses, injuries and disabilities. Cryo-Save India who has taken the initiative to organize the Professor’s visit believes that this will act as an impetus for people in India to accept stem cell banking as a new form of health protection for the future.
During his visit, Prof. McGuckin will engage with regulatory authorities to share information that will shape future direction and progress in cord blood banking and advances in patient treatments. He will also talk about his latest discoveries in Regenerative Medicine, including his recent creation of the world’s first artificial pancreas, which may have important implications in diabetes.
Prof McGuckin, who has recently been appointed as Scientific Director for Cryo-Save will be traveling to Bangalore, New Delhi and Mumbai.
Armed with 20 years of experience in stem cells, Professor McGuckin is an opinion leader who has been called upon by governments and hospitals around the world. He is also President of the Novus Sanguis Consortium, which brings together leading adult stem cell researchers and clinicians from across the world to work on specific diseases of the human condition, including heart disease, stroke, diabetes and organ degeneration.
About Cryo-Save Group
Cryo-Save Group is Europe’s largest adult stem cell storage bank, with more than 80,000 samples stored. The Company was established in 2000, is headquartered in The Netherlands, and owns or has access to, operating laboratory and storage facilities in Belgium, Germany and Dubai. Cryo-Save's services are available in 37 countries across three continents (Europe, Asia, and Africa).
Cryo-Save is a founding member of the International Tissue Engineering Research Association (ITERA), an international forum of scientists and researchers specialized in stem cells and tissue repair. Together with 5 universities in Europe and the Fraunhofer Institute, Cryo-Save has been selected to conduct fundamental research in the field of cryopreservation techniques for stem cells in an EU funded Framework Program called CRYSTAL.
Cryo-Save is focused on the collection and storage of ADULT stem cells derived from cord blood.
About Cryo-Save India
Cryo-Save India is headquartered in Bangalore with a state-of-the art, one-of-its-kind, fully automated adult stem cell storage facility. The facility at Bangalore covers 10,000 sq ft with a storage capacity of 150,000 samples, extendable to 300,000 immediately. 
Cryo-Save India will be the only company in India with its unique offering of dual-storage system and this will be available for the first time in the country. They are also the only company that does automatic processing to avoid manual intervention and contamination. The company will be offering the collection and storage of ADULT stem cells derived from cord blood. The services will be available across all metros and other cities.